Best Grants for Cancer Nonprofits in Arizona

Arizona cancer researchers at academic institutions or eligible nonprofits can seek American Cancer Society Discovery Boost Grants to support high-risk, high-reward exploratory cancer research across the continuum. Focused on cancer/oncology, these awards offer up to US $297,000 for developing methods, establishing feasibility, or piloting studies that can lead to larger future funding.

The NCI CURE Mentored Clinical Scientist Research Career Development Award (K08) aims to support individuals with clinical doctoral degrees in developing research careers that address national health-related needs. This program focuses on enhancing the research capabilities of underrepresented clinical scientists in cancer research, including health disparities. Awardees receive protected time for supervised research training, preparing them to compete for future research project grants. Key deadlines for applications span from February 2025 to October 2027.

Individuals being treated for cancer-related behavioral health conditions in Arizona and across the U.S. can receive up to US $2,000 to offset prescription copays, counseling, psychotherapy, and related transportation costs. The Healthwell Foundation supports underinsured patients whose income and insurance status meet its guidelines, helping reduce financial barriers to essential behavioral health care.

Underinsured patients being treated for amyloidosis in the U.S., including Arizona, can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. The Healthwell Foundation supports individuals whose insurance covers part of their cancer-related medications and whose household income falls within its federal poverty level guidelines.

Nonprofit, tax-exempt 501(c)(3) educational or research institutions in Arizona working on childhood cancer can seek funding for non-animal biomedical research methods. With a mission to advance alternatives to animal-based science, Alternatives Research & Development Foundation provides US $210,000 for pre-clinical projects improving childhood cancer knowledge or treatment using non-animal models.

Professional elderly blues musicians in Arizona facing emergency medical or basic living expenses can receive US $500 in assistance for needs like treatment, transportation, home care, utilities, or burial costs. The Pinetop Perkins Foundation pays creditors directly, and artists dealing with cancer-related or other serious health crises may be eligible if income and age requirements are met.

Nonprofit and other eligible U.S. organizations conducting cancer/oncology comparative clinical effectiveness research can apply for up to US $13,000,000 to improve care across the cancer continuum. With a mission to support patient-centered research, Patient-Centered Outcomes Research Institute provides funding for projects addressing screening barriers, treatment delivery, and survivorship needs, including work benefiting Arizona communities.

Cancer researchers conducting oncology studies to improve prevention, early detection, treatment, or survivorship care in U.S. communities can apply for pilot funding up to US $50,000. Focused on cancer outcomes, Indiana Clinical and Translational Sciences Institute supports IUSCCC member-led projects, and Arizona cancer nonprofits partnering with eligible investigators may benefit through collaborative research efforts.

Arizona cancer and health research organizations can access funding through the Patient-Centered Outcomes Research Institute for retrospective observational comparative effectiveness studies using existing data sources. Eligible public and private sector entities must focus on at least one approved topic, such as addressing cancer, maternal morbidity and mortality, mental and behavioral health, or rare diseases, with awards up to US $2,000,000.

Cancer research institutions and academic medical centers conducting translational oncology studies in the U.S. and territories, including Arizona, can seek funding to advance prevention, early detection, diagnosis, and treatment of organ-specific or biologically related cancers. National Institutes of Health SPORE P50 center grants support state-of-the-art, human biology–based projects that reach a translational human endpoint within the grant period.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. Heart of Illinois Community Foundation’s Cancer Care Specialists of Illinois Scholarship reviews applications monthly for residents of Macon, Moultrie, or Piatt County with a minimum 3.0 GPA.

Full-time radiation oncology faculty clinicians conducting cancer research in Arizona can seek multi-year career development support through this clinician scientist award. Focused on advancing cancer and radiation oncology research, the American Society for Radiation Oncology and American Cancer Society provide US $135,000 annually to help clinicians build independent research careers while maintaining clinical practice.

Practicing radiation oncologists conducting cancer research in the U.S., including those based in Arizona, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years for research across the cancer continuum. This award from the American Society for Radiation Oncology supports clinician-scientists advancing oncology care.

Arizona cancer-focused medical schools, hospitals, patient advocacy groups, and 501(c)(3) nonprofits can access funding through Incyte for programs that improve access to healthcare information and support patients with cancer and other diseases. Eligible projects include medical education, professional training, and patient care initiatives that align with Incyte’s healthcare and compliance guidelines.

Arizona cancer-focused medical schools, hospitals, patient advocacy groups, and eligible 501(c)(3) organizations can seek funding to support healthcare information for students, providers, patients, and caregivers. Focused on oncology and related diseases, Incyte invites healthcare-related charitable contributions, sponsorship, and membership requests that improve patient care and education for cancer communities.

Cancer research institutions and oncology-focused organizations in Arizona and beyond can seek funding for studies on combining radiation therapy with immunotherapy. With a mission to advance innovative cancer treatment, Radiation Oncology Institute provides support for projects exploring treatment optimization, toxicity reduction, education, and access to combined radiotherapy–immunotherapy, offering US $50,000 - US $100,000 over two years.

The Radiation Oncology Institute (ROI) Innovation Awards, offered by the American Society for Radiation Oncology, aim to accelerate innovative ideas in radiation therapy. Currently accepting applications for the 2026 awards, the program focuses on optimizing the combination of radiation therapy and immunotherapy to enhance cancer treatment outcomes. By supporting practical research, ROI strives to transform clinical practices and improve patient care in the fight against cancer.

Pfizer is offering a grant opportunity for independent medical education initiatives focused on Muscle Invasive Bladder Cancer (MIBC). This program aims to address the current knowledge gaps among healthcare professionals regarding emerging treatment data and its potential impact on clinical practices. By collaborating with Astellas, Pfizer seeks proposals that enhance awareness and understanding of the evolving MIBC landscape, ultimately improving patient outcomes in this critical area of unmet medical need.

The Joyce Bytof Memorial Cancer Survivors Scholarship, established by Joyce Bytof in collaboration with the American Cancer Society, supports childhood cancer survivors graduating from specific Wisconsin high schools. This scholarship aims to assist them in pursuing higher education despite the financial and academic challenges posed by their experiences. Joyce's legacy continues to inspire hope and resilience among young survivors as they strive for academic success and a brighter future.

The AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant supports innovative research on upper gastrointestinal malignancies, which are responsible for over one million deaths globally in 2023. This grant encourages collaboration between U.S. and Asian institutions, focusing on resistance, metastasis, and novel treatment strategies. Proposals should detail plans for clinical translation and are open to researchers at all career stages, especially those new to upper GI cancer research.

Bristol Myers Squibb Foundation Inc supports independent medical education to enhance healthcare professional competence and improve patient health outcomes. Their mission is to be a global leader in innovative medical education, focusing on evidence-based activities that address critical gaps in knowledge. By fostering excellence in healthcare, they aim to ensure measurable improvements in performance and patient outcomes across various disease areas.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The American Heart Association is seeking proposals to study the prevalence and treatment of cardiovascular, kidney, and metabolic diseases among cancer patients and survivors. Given the over 16.7 million cancer survivors in the U.S., this research aims to highlight critical health disparities, identify treatment modalities, and explore shared risk factors. Applications focusing on underrepresented populations and utilizing real-world data sources are especially encouraged, aiming to improve health outcomes in this vulnerable group.

The Juan Diego Guadiana Legacy Foundation Scholarship supports students from Las Cruces High School or Doña Ana County, especially those affected by cancer treatment or pursuing health-related fields. This scholarship is open to various backgrounds, including BiPOC and LGBTQIA+ communities. The foundation aims to empower students at different educational stages, ensuring they have the resources necessary to thrive in their academic and professional journeys.

The NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08) aims to enhance the careers of clinical scientists committed to cancer research. This NIH-supported program provides protected time for research and encourages underrepresented individuals in health-related sciences. With deadlines spanning from 2025 to 2027, the program focuses on training and developing the skills necessary to compete for significant research funding and address health disparities in cancer research.

This initiative aims to support research interventions targeting disparities in liver diseases and liver cancer among underserved populations in the U.S. It encourages innovative approaches to reduce health inequities and improve health outcomes. The funding opportunity is available through various deadlines for both standard and renewal applications, promoting multi-level strategies to address these critical health issues effectively.

The National Cancer Institute (NCI) invites applications for the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) program. This funding opportunity focuses on advanced pre-clinical research aimed at developing nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards will support the maturation of innovative nanomedicines using nanoparticles and nano-devices, enhancing cancer treatment efficacy. Successful projects will progress towards further NCI translational programs, such as the NExT initiative.